Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease

PLoS One. 2019 May 31;14(5):e0217922. doi: 10.1371/journal.pone.0217922. eCollection 2019.

Abstract

To meet the need for Parkinson's disease biomarkers and evidence for amount and distribution of pathological changes, MRI diffusion tensor imaging (DTI) has been explored in a number of previous studies. However, conflicting results warrant further investigations. As tissue microstructure, particularly of the grey matter, is heterogeneous, a more precise diffusion model may benefit tissue characterization. The purpose of this study was to analyze the diffusion-based imaging technique restriction spectrum imaging (RSI) and DTI, and their ability to detect microstructural changes within brain regions associated with motor function in Parkinson's disease. Diffusion weighted (DW) MR images of a total of 100 individuals, (46 Parkinson's disease patients and 54 healthy controls) were collected using b-values of 0-4000s/mm2. Output diffusion-based maps were estimated based on the RSI-model combining the full set of DW-images (Cellular Index (CI), Neurite Density (ND)) and DTI-model combining b = 0 and b = 1000 s/mm2 (fractional anisotropy (FA), Axial-, Mean- and Radial diffusivity (AD, MD, RD)). All parametric maps were analyzed in a voxel-wise group analysis, with focus on typical brain regions associated with Parkinson's disease pathology. CI, ND and DTI diffusivity metrics (AD, MD, RD) demonstrated the ability to differentiate between groups, with strongest performance within the thalamus, prone to pathology in Parkinson's disease. Our results indicate that RSI may improve the predictive power of diffusion-based MRI, and provide additional information when combined with the standard diffusivity measurements. In the absence of major atrophy, diffusion techniques may reveal microstructural pathology. Our results suggest that protocols for MRI diffusion imaging may be adapted to more sensitive detection of pathology at different sites of the central nervous system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Stem / diagnostic imaging
  • Brain Stem / pathology
  • Diagnostic Imaging*
  • Diffusion Magnetic Resonance Imaging
  • Diffusion Tensor Imaging*
  • Female
  • Gray Matter / diagnostic imaging
  • Gray Matter / pathology
  • Humans
  • Male
  • Middle Aged
  • Nerve Degeneration / diagnosis*
  • Nerve Degeneration / diagnostic imaging
  • Nerve Degeneration / pathology
  • Parkinson Disease / diagnosis*
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / pathology
  • Substantia Nigra / diagnostic imaging
  • Substantia Nigra / pathology
  • Thalamus / diagnostic imaging
  • Thalamus / pathology

Grants and funding

The work done by TRH, PS and TF was supported by the EU‐JPND via the Research Council of Norway [grant number 237250]; South‐Eastern Norway Regional Health Authority [grant numbers 20111093, 2014086]; Research Council of Norway [grant numbers 217780, 226074]; Akershus University Hospital grant; the work done by IR, LA, NNW, ZB was supported by the European Regional Development Fund-Project “National infrastructure for biological and medical imaging” [grant number CZ.02.1.01/0.0/0.0/16_013/0001775]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.